XML 53 R38.htm IDEA: XBRL DOCUMENT v3.22.1
Redeemable Noncontrolling Interest (Tables)
 12 Months Ended
Dec. 31, 2021
Noncontrolling Interest [Abstract]  
Summary of Net Income Attributable to Vtv Therapeutics Inc The following is a summary of net income attributable to vTv Therapeutics Inc. and transfers to noncontrolling interest:

 

December 31,

 

 

2021

 

 

2020

 

 

2019

 

Net loss attributable to vTv Therapeutics Inc.

   common shareholders

$

(12,987

)

 

$

(8,499

)

 

$

(17,913

)

Increase in vTv Therapeutics Inc. accumulated

   deficit for purchase of LLC Units as a result

   of common stock issuances

 

(5,084

)

 

 

(8,943

)

 

 

(17,971

)

Change from net loss attributable to

   vTv Therapeutics Inc. common shareholders

   and transfers to noncontrolling interest

$

(18,071

)

 

$

(17,442

)

 

$

(35,884

)